7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Dynybil C et al. | [The effect of osteoprotegerin on tendon-bone healing after reconstruction of the anterior cruciate ligament: a histomorphological and radiographical study in the rabbit]. | 2006 Mar-Apr | Z Orthop Ihre Grenzgeb | pmid:16625448 |
Endres S et al. | [Comparative in vitro analysis of vacuum plasma-sprayed titanium implants--evaluation of OPG, Osteokalzin and AP expression]. | 2006 Nov-Dec | Z Orthop Ihre Grenzgeb | pmid:17187340 |
An JJ et al. | Expression and regulation of osteoprotegerin in adipose tissue. | 2007 | Yonsei Med. J. | pmid:17963332 |
Xiao HL et al. | [Expression and activity determination of TNFR domain of osteoprotegerin in E.coli and corresponding antibody preparation]. | 2005 | Yi Chuan | pmid:16257908 |
Geng L et al. | [Association between Val80 polymorphism of the CYP19 gene, A163G polymorphism of the OPG gene and bone mineral density in post-menopausal Chinese women]. | 2007 | Yi Chuan | pmid:17989043 |
Ming LG et al. | [Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro]. | 2012 | Yao Xue Xue Bao | pmid:22512027 |
Qiu S et al. | [Design and activity verification of human parathyroid hormone (1-34) mutant protein]. | 2012 | Yao Xue Xue Bao | pmid:22993856 |
Wang L et al. | [Inhibitory effect of diacerein on osteoclastic bone destruction and its possible mechanism of action]. | 2006 | Yao Xue Xue Bao | pmid:16927832 |
Kang BH et al. | [Expression of truncated fragment of human OPG in CHO-DHFR- cells and its bioactivity characterization]. | 2009 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | pmid:19900367 |
Shao B et al. | [RANKL and OPG expression in bone marrow-derived mesenchymal stem cells of ovariectomied promotes osteoclast development and enhances its function]. | 2013 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | pmid:24321069 |
Miyaji Y et al. | Pharmacokinetics and disposition of recombinant human osteoprotegerin (rhOPG) after intravenous administration in female fischer rats. | 2009 | Xenobiotica | pmid:19255937 |
Larussa T et al. | No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. | 2012 | World J. Gastroenterol. | pmid:22529691 |
Sood SK et al. | Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease. | 2011 | World J Surg | pmid:21748518 |
Fahrleitner-Pammer A et al. | Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status. | 2003 | Wien. Klin. Wochenschr. | pmid:12793029 |
Fahrleitner A et al. | Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. | 2002 | Wien. Klin. Wochenschr. | pmid:12602117 |
Wagner D and Fahrleitner-Pammer A | Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help? | 2010 | Wien Med Wochenschr | pmid:20714810 |
Winzer M et al. | Glycitein decreases the generation of murine osteoclasts and increases apoptosis. | 2010 | Wien Med Wochenschr | pmid:20714813 |
Gruber R | Cell biology of osteoimmunology. | 2010 | Wien Med Wochenschr | pmid:20714814 |
Beke D et al. | [Clinical relevance of biomarkers in cancer related bone disease]. | 2007 | Wien Med Wochenschr | pmid:17922085 |
Kerschan-Schindl K | Bone turnover in hyperparathyroidism. | 2013 | Wien Med Wochenschr | pmid:22805761 |